STOCK TITAN

Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)

Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) has completed its acquisition of Carevive Systems, a health technology company specializing in oncology. Carevive's platform is used for treatment care planning, clinical trial screening, care coordination, remote patient monitoring, and post-treatment care. This acquisition will enhance Health Catalyst's capabilities in oncology care and patient-reported outcomes. Both companies aim to leverage data and analytics to improve patient care and outcomes. The integration promises to deliver innovative solutions to cancer centers and provide researchers with valuable real-world data.

Loading...
Loading translation...

Positive

  • Health Catalyst acquires Carevive, enhancing oncology capabilities.
  • Carevive's platform aids in treatment care planning, clinical trial screening, and patient monitoring.
  • Acquisition expands Health Catalyst's data analytics in oncology.
  • Joint efforts aim to improve patient care and outcomes through advanced data utilization.
  • Integration promises new solutions for cancer centers and enhanced real-world data for researchers.

Negative

  • Acquisition risks include potential integration challenges.
  • No financial details provided, leaving ROI and cost implications unclear.
  • Success heavily depends on the effective merging of technologies and teams.

News Market Reaction

-1.19%
1 alert
-1.19% News Effect

On the day this news was published, HCAT declined 1.19%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SALT LAKE CITY, June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Carevive Systems ("Carevive"), a leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer.

Oncology providers and life science researchers use Carevive's flagship platform and/or Carevive data in routine clinical practice for treatment care planning, clinical trial screening, care coordination, remote patient monitoring, and/or post-treatment care. In combination with Carevive, Health Catalyst will have a strengthened ability to support care and process improvement in oncology and gain new insight into patient-reported outcomes and oncology registry data.

"We are thrilled to welcome Carevive to Health Catalyst. Oncology is one of the most strategic and important delivery programs within any health system, and access to high-quality data is essential to its success. We are grateful to have the opportunity to work alongside Carevive, a team that is mission-aligned and deeply committed to leveraging data and analytics to improve patient care and outcomes in this space," said Dan Burton, CEO of Health Catalyst.

"Today marks a pivotal moment for our patients and clients. At Carevive, we're thrilled and deeply honored to join forces with Health Catalyst. This partnership embodies our shared commitment to advancing healthcare through the strategic utilization of technology, data, and analytics within healthcare organizations," said Bruno Lempernesse, CEO of Carevive. "Central to Carevive's mission is amplifying the patient's voice in cancer care. By uniting with Health Catalyst, we're not just expanding our capabilities; we're also enhancing our ability to make a difference. With their expertise and solutions augmenting ours, Carevive is poised to deliver even more innovative solutions to cancer centers and provide researchers with unparalleled real-world data. Together, we're shaping a future where patient-centered care and groundbreaking research converge seamlessly."

About Health Catalyst
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Media Contact:
Amanda Hundt
Vice President, Corporate Communications
amanda.hundt@healthcatalyst.com
575-491-0974

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/health-catalyst-acquires-oncology-focused-health-technology-company-carevive-302165472.html

SOURCE Health Catalyst

FAQ

What did Health Catalyst acquire?

Health Catalyst acquired Carevive Systems, an oncology-focused health technology company.

What is Carevive's platform used for?

Carevive's platform is used for treatment care planning, clinical trial screening, care coordination, remote patient monitoring, and post-treatment care.

How will the acquisition of Carevive benefit Health Catalyst?

The acquisition will enhance Health Catalyst's capabilities in oncology care, support care and process improvement, and provide new insights into patient-reported outcomes and oncology registry data.

When was the acquisition of Carevive announced?

The acquisition of Carevive was announced on June 6, 2024.

What is the primary focus of the partnership between Health Catalyst and Carevive?

The primary focus is leveraging data and analytics to improve patient care and outcomes in oncology.
Health Catalyst

NASDAQ:HCAT

HCAT Rankings

HCAT Latest News

HCAT Latest SEC Filings

HCAT Stock Data

130.14M
63.55M
3.52%
79.72%
7.46%
Health Information Services
Services-computer Programming, Data Processing, Etc.
Link
United States
SOUTH JORDAN